TRAIL human, , recombinant, exprimé en cellules NSO, > 97 %( SDS -PAGE ),POUDRE lyophilisée

Code: t5694-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Analysis Note

Induces cytotoxicity in mouse L-929 cells in the presence of actinomycin D.

Application

TRAIL human was used to induce cytotoxicity...


en savoir plus

Votre prix
$845.13 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Analysis Note

Induces cytotoxicity in mouse L-929 cells in the presence of actinomycin D.

Application

TRAIL human was used to induce cytotoxicity in A549, a human lung carcinoma cell line.

Biochem/physiol Actions

TNF-related apoptosis-inducing ligand (TRAIL) is a type II transmembrane protein that belongs to TNF family. It is present in both soluble as well as membrane-bound form and can induce rapid apoptosis of various transformed cell lines but not the normal cells. Additionally, the product can also induces apoptotic cell death in TRAIL-sensitive U343MGcells.

Type II transmembrane protein of the TNF superfamily. Ligand for apoptosis-inducing death receptors DR4 and DR5, decoy receptors DcR1 and DcR2, and osteoprotegerin. Approximately 28% amino acid sequence identity to FAS ligand. Human and mouse TRAIL share 65% sequence identity.

Physical form

Lyophilized from a 0.2 µm filtered solution in phosphate buffered saline containing 0.5 mg bovine serum albumin.

assay>97% (SDS-PAGE)
biological sourcehuman
descriptionN-terminal 6X histidine-tagged extracellular domain
formlyophilized powder
Gene Informationhuman ... TNFSF10(8743)
impuritiesendotoxin, tested
mol wtpredicted mol wt ~21 kDa, 24 kDa by SDS-PAGE
Quality Level200
recombinantexpressed in NSO cells
storage temp.−20°C
technique(s)cell culture | mammalian: suitable
UniProt accession no.P50591
Ce produit répond aux critères suivants: